- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
Metildigoxin is a cardiovascular drug used to treat heart failure and atrial fibrillation. It is a type of digitalis glycoside, a group of drugs that act on the heart muscle to increase the force of contraction and slow the heart rate. Metildigoxin is used to treat congestive heart failure, a condition in which the heart is unable to pump enough blood to meet the body's needs. It is also used to treat atrial fibrillation, an irregular heartbeat that can lead to stroke and other complications. Metildigoxin works by increasing the force of contraction of the heart muscle, which helps the heart pump more blood.
Metildigoxin is available in both generic and brand-name forms. It is available as a tablet, capsule, and injection. Common brand names include Lanoxin, Digitek, and Digox.
The Metildigoxin market is highly competitive, with many companies offering generic and brand-name versions of the drug. Companies in the market include Pfizer, Novartis, Merck, GlaxoSmithKline, Sanofi, and Teva Pharmaceuticals. Show Less Read more